Pelvic Lymph Node Irradiation Including Pararectal Sentinel Nodes for Prostate Cancer Patients

We aimed to assess the dosimetric impact of advanced delivery radiotherapy techniques using either intensity modulated x-ray beams (IMXT), volumetric modulated arc therapy (VMAT), or intensity modulated proton therapy (IMPT), for high-risk prostate cancer patients with sentinel nodes in the pararectal region. Twenty high-risk prostate cancer patients were included in a prospective trial evaluating sentinel nodes on pelvic SPECT acquisition. To be eligible for the dosimetric study, patients had to present with pararectal sentinel nodes usually not included in the clinical target volume encompassing the pelvic lymph nodes. Radiotherapy-plans including the prostate, the seminal vesicles, and the pelvic lymph nodes with the pararectal sentinel nodes were optimized for 6 eligible patients. IMXT and IMPT were delivered with 7 and 3 beams respectively and VMAT with 2 arcs. Results were assessed with Dose-Volume Histograms and predictive normal tissue complication probabilities (NTCPs) models between the three competing treatment modalities aiming to deliver a total dose of 50.4 Gy in 1.8 Gy daily fractions. Target coverage was optimized with IMPT when compared to IMXT and VMAT. Coverage of the sentinel node was slightly better with IMXT (D98% 5 57.3 ± 5.1 Gy) when compared with VMAT (D98% 5 56.2 ± 4.1 Gy). The irradiation of rectal, bladder, small bowel, and femoral heads volumes was significantly reduced with IMPT when compared to IMXT and VMAT. NTCPs rates for rectal and bladder ≥ grade-3 late toxicity were better with IMPT (0.4 ± 0.0% and 0.0 ± 0.0%) compared with IMXT (4.6 ± 3.3% and 1.4 ± 1.1%), and VMAT (4.5 ± 4.0% and 1.6 ± 1.6%), respectively. Acceptable dose-volume distributions and low rectal and urinary NTCPs were estimated to geometrically complex pelvic volumes such as the ones proposed in this study using IMXT, VMAT and IMPT. IMPT succeeded, however, to propose the best physical and biological treatment plans compared to both X-ray derived plans.

[1]  Yashuang Zhao,et al.  Dosimetric comparison of intensity modulated radiotherapy and three-dimensional conformal radiotherapy in patients with gynecologic malignancies: a systematic review and meta-analysis , 2012, Radiation Oncology.

[2]  O. Ratib,et al.  Target volume definition in high-risk prostate cancer patients using sentinel node SPECT/CT and 18 F-choline PET/CT , 2012, Radiation oncology.

[3]  Issam El Naqa,et al.  Pelvic normal tissue contouring guidelines for radiation therapy: a Radiation Therapy Oncology Group consensus panel atlas. , 2012, International journal of radiation oncology, biology, physics.

[4]  A. Sahgal,et al.  A treatment planning and acute toxicity comparison of two pelvic nodal volume delineation techniques and delivery comparison of intensity-modulated radiotherapy versus volumetric modulated arc therapy for hypofractionated high-risk prostate cancer radiotherapy. , 2012, International journal of radiation oncology, biology, physics.

[5]  J. Fontenot,et al.  Single-arc volumetric-modulated arc therapy can provide dose distributions equivalent to fixed-beam intensity-modulated radiation therapy for prostatic irradiation with seminal vesicle and/or lymph node involvement. , 2012, The British journal of radiology.

[6]  Bijan Arjomandy,et al.  Patient-specific quality assurance for prostate cancer patients receiving spot scanning proton therapy using single-field uniform dose. , 2011, International journal of radiation oncology, biology, physics.

[7]  Patrick Cheung,et al.  Assessing the role of volumetric modulated arc therapy (VMAT) relative to IMRT and helical tomotherapy in the management of localized, locally advanced, and post-operative prostate cancer. , 2011, International journal of radiation oncology, biology, physics.

[8]  Michael Gillin,et al.  Verification of patient-specific dose distributions in proton therapy using a commercial two-dimensional ion chamber array. , 2010, Medical physics.

[9]  Uwe Titt,et al.  Commissioning of the discrete spot scanning proton beam delivery system at the University of Texas M.D. Anderson Cancer Center, Proton Therapy Center, Houston. , 2009, Medical physics.

[10]  R. Peschel,et al.  Whole pelvic radiotherapy versus prostate only radiotherapy in the management of locally advanced or aggressive prostate adenocarcinoma. , 2009, International journal of radiation oncology, biology, physics.

[11]  D. Yeung,et al.  Dosimetric study of pelvic proton radiotherapy for high-risk prostate cancer. , 2009, International journal of radiation oncology, biology, physics.

[12]  F. Lohr,et al.  Volumetric modulated arc therapy (VMAT) vs. serial tomotherapy, step-and-shoot IMRT and 3D-conformal RT for treatment of prostate cancer. , 2009, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[13]  Habib Zaidi,et al.  RapidArc, intensity modulated photon and proton techniques for recurrent prostate cancer in previously irradiated patients: a treatment planning comparison study , 2009, Radiation oncology.

[14]  C. Bastide,et al.  Commentary on: Validation of sentinel lymph node dissection in prostate cancer: experience in more than 2,000 patients , 2009, European Journal of Nuclear Medicine and Molecular Imaging.

[15]  C. Ménard,et al.  RTOG GU Radiation oncology specialists reach consensus on pelvic lymph node volumes for high-risk prostate cancer. , 2009, International journal of radiation oncology, biology, physics.

[16]  G. Holl,et al.  Validation of sentinel lymph node dissection in prostate cancer: experience in more than 2,000 patients , 2009, European Journal of Nuclear Medicine and Molecular Imaging.

[17]  Marco Krengli,et al.  Conformal radiotherapy of clinically localized prostate cancer: analysis of rectal and urinary toxicity and correlation with dose-volume parameters. , 2009, Tumori.

[18]  M. Krengli,et al.  Conformal Radiotherapy of Clinically Localized Prostate Cancer: Analysis of Rectal and Urinary Toxicity and Correlation with Dose-Volume Parameters , 2009 .

[19]  K. Otto,et al.  Volumetric modulated arc therapy for delivery of prostate radiotherapy: comparison with intensity-modulated radiotherapy and three-dimensional conformal radiotherapy. , 2008, International journal of radiation oncology, biology, physics.

[20]  Luca Cozzi,et al.  A treatment planning study comparing volumetric arc modulation with RapidArc and fixed field IMRT for cervix uteri radiotherapy. , 2008, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[21]  O. Odland,et al.  Intensity-modulated radiotherapy of pelvic lymph nodes in locally advanced prostate cancer: planning procedures and early experiences. , 2008, International journal of radiation oncology, biology, physics.

[22]  B. Schaffner.  Proton dose calculation based on in-air fluence measurements , 2008, Physics in medicine and biology.

[23]  M. Flentje,et al.  Does Intensity Modulated Radiation Therapy (IMRT) prevent additional toxicity of treating the pelvic lymph nodes compared to treatment of the prostate only? , 2008, Radiation oncology.

[24]  W. Ulmer.  Theoretical aspects of energy–range relations, stopping power and energy straggling of protons , 2007 .

[25]  Lei Dong,et al.  Investigation of bladder dose and volume factors influencing late urinary toxicity after external beam radiotherapy for prostate cancer. , 2007, International journal of radiation oncology, biology, physics.

[26]  M. Alber,et al.  Optimized coverage of high-risk adjuvant lymph node areas in prostate cancer using a sentinel node-based, intensity-modulated radiation therapy technique. , 2007, International journal of radiation oncology, biology, physics.

[27]  F Foppiano,et al.  Fitting late rectal bleeding data using different NTCP models: results from an Italian multi-centric study (AIROPROS0101). , 2004, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[28]  M. Hoogeman,et al.  Impact of volume and location of irradiated rectum wall on rectal blood loss after radiotherapy of prostate cancer. , 2004, International journal of radiation oncology, biology, physics.

[29]  W. Ulmer,et al.  The inverse problem of a Gaussian convolution and its application to the finite size of the measurement chambers/detectors in photon and proton dosimetry. , 2003, Physics in medicine and biology.

[30]  C. Ling,et al.  Late rectal toxicity after conformal radiotherapy of prostate cancer (I): multivariate analysis and dose-response. , 2000, International journal of radiation oncology, biology, physics.

[31]  S. Spirou,et al.  Dose calculation for photon beams with intensity modulation generated by dynamic jaw or multileaf collimations. , 1994, Medical physics.

[32]  M. Goitein,et al.  Fitting of normal tissue tolerance data to an analytic function. , 1991, International journal of radiation oncology, biology, physics.

[33]  Anna-Karin Agren Cronqvist,et al.  Quantification of the response of heterogeneous tumours and organized normal tissues to fractionated radiotherapy , 1995 .

[34]  A Brahme,et al.  Tumour and normal tissue responses to fractionated non-uniform dose delivery. , 1992, International journal of radiation biology.